WFA Funded Grants 2009 - 2025

Investigating the Immune and Cytoreductive Activities of Gilvetmab Alone and in Combination with Indoleamine2,3-Dioxygenase Inhibition in Canine Urothelial Carcinoma

Fecal microbiota transplantation for treatment of canine atopic dermatitis

4MU for Palliation of Pulmonary Fibrosis in Dogs

Rametrix Technologies, Inc (RTI) - Westie Foundation of America, Inc. (WFA) Canine Cancer and Health Research Partnership (CCHRP)

Evaluation of the Effects of Diluted Sodium Hypochlorite on Skin Microbiome in Dogs with Superficial Pyoderma and Atopic Dermatitis: a Single Blinded, Randomized, Controlled Clinical Trial

Investigation of the Role of Staphylococcus pseudintermedius Phenol-soluble Modulins in Canine Pyoderma

Monies used for the costs of postage and supplies (blood tubes, boxes, printing of health questionnaires, sample release forms)

Accessing very large patient cohorts through social media to assess the utility of novel treatment options; modelling on immuno-suppressive therapy of IPF

Bladder Carcinogen Exposures in Pet Dogs.

Towards Curative Outcomes in Canine Hemangiosarcoma

Adoptive Natural Killer (NK) Cell Immunotherapy for Canine Lymphoma

Duration of Antibiotic Therapy for Canine Superficial Pyoderma: Is the One-Week Post Resolution of Clinical Signs a Valid Rule-of-Thumb?

Investigation on the Molecular Crosstalk between Canine Atopic Skin and Microbes: Unraveling Potential Pathomechanisms for Chronic Recurrent Skin Infections.

Investigating the potential of Phage Therapy to tackle Staphylococcus pseudintermedius infection in dogs

Characterizing the LINE-1 Transcriptome in Canine High-grade Peripheral T-cell Lymphoma by RNAseq to Gain Insight into Mechanisms of Drug and Immune Resistance

Luteinizing Hormone Receptor Activation in Canine Hemangiosarcoma Cells

Investigation on the in vitro effects of resveratrol on peripheral blood mononuclear cells harvested from healthy and atopic dogs

Discovery of Novel Biomarkers of Canine Atopic Dermatitis through Lipid Profiling.

Molecular Epidemiology of Methicillin- resisitant Staphylococcus pseudintermedius in the United States.

Evaluation of the Serum and Cutaneous Levels of Chemokines in Atopic Dogs.

Sobetirome, a thyroid mimetic, for treatment of Pulmonary Fibrosis in West Highland White terriers.

Mechanisms of Allergic Disease in the West Highland White Terrier.

Harnessing a Dog’s Own Immune System to Kill Lymphoma Tumor Cells.

Capturing Tumor Cells in Canine Blood.

Effect of Lokivetmab on Tissue Biomarkers of Canine Atopic Dermatitis using RNA Sequencing.

The Role of Complex Translocations Associated with TP53 Somatic Mutations for Aiding Prognosis of Canine Diffuse Large B-cell Lymphoma.

Intralymphatic Immunotherapy for the Treatment of Canine Atopic Dermatitis.

The Genetics of Keratoconjuctivitis sicca (KCS) in the West Highland White Terrier.

Targeting the Cancer Epigenome: The Effect of Specific Histone Lysine Methyltransferase Inhibition in Canine B-Cell Lymphoma.

Defining the Genetic Basis of Inflammatory Bowel Disease.

Is Defective Secretion of Antimicrobial Peptides Associated with Reduced Microbicidal Effects in Atopic Keratinocytes?

To convene geneticists (medical and veterinary) for a workshop with the goal to determine how to best collect, store and distribute biological samples from dogs to better advance comparative research.

Searching for a plasma marker for PF in Westies; provide funding to ship plasma samples from affected dogs in liquid nitrogen canisters to U Alabama.

Finding the Mutations that increase Susceptibility to Transitional Cell Carcinoma in the Scottish Terrier, West Highland Terrier, and Shetland Sheepdog.

Finding the Mutations that increase Susceptibility to Transitional Cell Carcinoma in the Scottish Terrier, West Highland Terrier, and Shetland Sheepdog.

Establishing Best Practices in the Treatment of Atopic Dermatitis to Prevent Antimicrobial Resistance.

Evaluating the Contribution of Fungal Infection to the Pathogenesis of Atopic Dermatitis: Putting Evidence under the Use of Antifungal Medication

Providing money for mailing blood samples and assembling informational kits about PF research.

WFA fundraised the budget of $120,000+ to fund this conference.

Probiotic therapy to treat Inflammatory Bowel disease.

Placebo-controlled trial of T-cell receptor (TCR) peptide treatment in dogs with non-responsive atopic dermatitis.

Genomic Resources for the Control of Canine Pyoderma

Genetics of Atopic Dermatitis.

*Funds placed in a FedEx account to be used for shipment of blood samples for banking at NCSU

Atopic dermatitis genome wide association study

Development of Anti-IgE Peptide for treatment of Canine Allergy.

Association mapping study of Legg-Calve-Perthes Disease in the West Highland White Terrier, Yorkshire Terrier, and Miniature Pinscher.

Searching for a genetic marker for CMO using snip chip analysis

*Money to be used for sample collection, storing, freezing at Virginina Tech and shipping samples to Switzerland

Money used on a case by case basis to pay for CT scans of dog’s lungs to confirm a diagnosis of IPF; followed by treatment with adult bone marrow stem cells.

Canine Cancer Campaign

Improved Imaging to Monitor Therapy Response of Urinary Bladder Cancer Using 3D Volume Ultrasonography

Studying Immune System’s Response to Allergens.